Delivery Order SPE2DX15D3003-SPE2DX24F5N0B
Award Date 5/8/24
Potential Completion Date 5/9/24
Potential Value $26K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $71,540.25. It is for the supply of KISQALI 600 MG DAILY DOSE 63S, a pharmaceutical product. The contract has an ultimate completion date of June 13, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $8,593.71 under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is for the drug...
- This federal contract award is a delivery order valued at $8,605.98, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of KISQALI 400 MG DAILY DOSE 42S, a pharmaceutical product, with a performance period ending on May 16, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $19,323.20, is for the delivery of KISQALI 600 MG DAILY DOSE 63S, a medication, to support military healthcare programs. It is a firm fixed-price delivery order contract with an ultimate completion date of August 19, 2024. Amerisourcebergen has been awarded multiple indefinite delivery contracts (IDCs) by the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corporation for $17,752.54 to provide KISQALI 600 mg daily dose pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to efficiently procure essential medical commodities, including specialty, brand name, generic, and...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $12,599 firm-fixed price contract is for the supply of KISQALI 600 MG DAILY DOSE 63S, a specialty cancer medication, with an ultimate completion date of August 15, 2024. This order is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,440.05 delivery order is for the supply of KISQALI 200 mg daily dose medication, with a completion date of November 7, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,204.67 firm fixed-price delivery order is for the supply of KISQALI 400 MG DAILY DOSE 42S, a prescription medication, with a period of performance through May 9, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,225.95 Firm Fixed Price Delivery Order covers the procurement of KISQALI 400 MG DAILY DOSE 42S, a specialty medication. The contract has an ultimate completion date of December 16, 2024 and was awarded on December 13, 2024. There was no set-aside designation used for this award. Amerisourcebergen holds a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,231.14, is for the delivery of KISQALI 400 MG DAILY DOSE 42S, a pharmaceutical product. The contract has an ultimate completion date of June 18, 2025. This award is not set-aside and was competed openly. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...